Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Alimera Sciences Q1 EPS $(0.12) Misses $(0.06) Estimate, Sales $23.01M Beat $22.25M Estimate

Author: Benzinga Newsdesk | May 14, 2024 07:35am

Alimera Sciences (NASDAQ:ALIM) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.06) by 100 percent. This is a 83.1 percent increase over losses of $(0.71) per share from the same period last year. The company reported quarterly sales of $23.01 million which beat the analyst consensus estimate of $22.25 million by 3.42 percent. This is a 69.87 percent increase over sales of $13.55 million the same period last year.

Posted In: ALIM